Blomgren H, Blom U, Ulén H
Cancer Immunol Immunother. 1986;21(1):31-8. doi: 10.1007/BF00199374.
The possible relation between the site of primary intracranial tumors and mitogenic responses of blood lymphocytes was analyzed in 115 patients who had not undergone surgery or received any radiation or chemotherapy. Some of the patients had however received corticosteroid treatment. PHA responses were impaired in nonsteroid treated patients with tumors affecting the left cerebral hemisphere. They were normal in patients with tumors affecting the right cerebral hemisphere or central structures of the brain or tumors growing in the posterior fossa of the skull. Lymphocyte responses to PPD were normal in patients with hemispheric or posterior fossa tumors. However, the PPD response was sharply reduced in patients with central tumors. The results could not be explained by different histological tumor types or anticonvulsant medication in the various patient groups. In addition, the capacity of sera to promote mitogen stimulation of lymphocytes did not differ significantly between the patient groups. It is speculated that intracranial tumors may interfere with the function of certain centers in the brain which are involved in the regulation of lymphocyte responses.
在115例未接受过手术、放疗或化疗的患者中,分析了原发性颅内肿瘤部位与血液淋巴细胞有丝分裂反应之间的可能关系。不过,部分患者接受过皮质类固醇治疗。在未接受类固醇治疗且肿瘤影响左脑半球的患者中,PHA反应受损。在肿瘤影响右脑半球、脑中央结构或生长于颅后窝的患者中,PHA反应正常。半球或颅后窝肿瘤患者对PPD的淋巴细胞反应正常。然而,中央肿瘤患者的PPD反应明显降低。结果无法用不同患者组中不同的肿瘤组织学类型或抗惊厥药物来解释。此外,各患者组之间血清促进淋巴细胞有丝分裂刺激的能力无显著差异。据推测,颅内肿瘤可能干扰了大脑中某些参与淋巴细胞反应调节的中枢功能。